Following the release of the EMA recommendations in 2020 [10], testing for DPD deficiency either biochemically by measuring plasma uracil levels or by genotyping specific DPYD SNP risk alleles has significantly increased in many European countries [40]. Here, DPYD is linked to dihydropyrimidine dehydrogenase deficiency.